COVID-19 Ab Rapid Test - India CDSCO Medical Device Registration

COVID-19 Ab Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000034_e87d197c71df90fb1babb8e773134f8b_1d9fe7b11309c2618b00d879a4ede860. This device is marketed under the brand name Aridia. The license holder is Athenese-Dx Private Limited, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

COVID-19 Ab Rapid Test

UID: MFG/IVD/2020/000034_e87d197c71df90fb1babb8e773134f8b_1d9fe7b11309c2618b00d879a4ede860

Brand Name

Aridia

License Holder

Athenese-Dx Private Limited

Device Class

Class C

Approving Authority

Central Drug Standard Control Organisation, South Zone

Product Information

The TRUSTline COVID-19 Ab Rapid Test is a single use lateral flow immunoassay rapid test intended for qualitative detection of anti-SARS-CoV-2 antibodies in human serum and plasma or whole blood containing EDTA, heparin or citrate anti-coagulants. The TRUSTline COVID-19 Ab Rapid Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2 infection

Class C

Brand: TRUSTline

Class D